Quantifying CAR T Cells Activity Against AML - Model Selection Based on In Vitro Cytolytic Assays

Explore a comprehensive seminar on quantifying CAR T cell activity against Acute Myeloid Leukemia (AML) through model selection based on in vitro cytolytic assays. Presented by Dr. Philipp Altrock as part of the Mathematical Oncology seminar series, this 1-hour and 13-minute talk delves into the cutting-edge research in immunotherapy for AML treatment. Gain insights into the mathematical modeling approaches used to evaluate the effectiveness of CAR T cells in targeting AML cells, and understand the importance of in vitro cytolytic assays in this process. Learn about the latest advancements in CAR T cell therapy and its potential impact on AML treatment strategies. This seminar is ideal for researchers, oncologists, and students interested in the intersection of immunotherapy, mathematical modeling, and cancer treatment.